As a part of our study on the use of isotopic analogues as the internal standard (IS) for the quantitation of drug analytes, this article reports on the performance characteristics of 2Hs-butalbital and 13C4-butalhital with particular focus on (1) determining and comparing the effectiveness of the 2H-and ~3C-analogues in serving as the ISs for quantitation; (2) understanding the "cross.contribution" phenomenon underlying the effectiveness of selected ion pairs used for quantitation purpose; and (3) examining whether the same characteristics, observed in our preliminary report for the secobarbital/2Hs.secobarbital/13C4-secobarbital system, also exist in the butalbital/2Hs-butalbital/~3C4.butalbital system. Adapting similar procedures applied to our previous study on the secobarbital system, we observed that (1) both labeled analogues (13C4-butalbital and 2Hs-butalbital) cause more significant cross-contributions to ions designated for butalbital than butalbital to the labeled analogues; (2) compared to 2Hs-butalbital, 13C4-butalbital appears to cause less cross-contributions to ions designated for butalbital; (3) cross-contribution between the following ion pairs are minimal: m/z 200/196, 1991195, 185/181 03C4.butalbital as the IS) and m/z 201/196 (2Hs-butalbital as the IS). It is also concluded that the butalbital/2Hs-butalbital system exhibits the same concentration dependency phenomenon observed in the secobarbital/ 2Hs-secobarbital system, that is, ratios of ion pairs designated for these two isotopic analogues (resulting from routine gas chromatography-mass spectrometry protocol) increase as their concentrations are diluted. (In parallel with the secobarbital/ 13C4-secobarbital system, the butalbital/13C4-butalbital system does not exhibit this phenomenon.)
Introduction
The use of a mass spectrometric device as the detector for quantitation has been a topic of considerable interest and discussion in the mass spectrometry community (1). Selected ion monitoring (SIM) gas chromatography-mass spectrometry (GC-MS) methodologies are now routinely used for the quantitation of analytes in complex matrices (2) . One major component of this approach involves the use of isotopic (mainly deuterated) analogues of the analytes as the internal standards (IS) for assay calibration. We (3) (4) (5) (6) (7) (8) (9) (10) and others (11) (12) (13) (14) have made substantial efforts studying various problems related to this approach (isotopic analogues as IS for quantitation), using drugs of abuse in biological media as examples. Recently, we presented some preliminary data (9) showing a distinct difference when 2Hs-secobarbital and 13C4-secobarbital were used as the ISs for the quantitation of secobarbital.
This study thoroughly examines a parallel butalbital system (butalbital/2Hs-butalbital/13C4-butalbital) to determine if the phenomenon reported for the secobarbital system also exists. Observed data are evaluated and analyzed with additional insights. Distinct characteristics of ~H-and 13C-analogues, pertinent to their serving as the ISs, are presented. Possible interpretations of mechanisms underlying the observed characteristics are also attempted.
Materials and Methods

Materials
13C4-Butalbital (an IS) in 1 mg/mL methanol solution (99% purity) was provided by Isotec (Miamisburg, OH). Butalbital (the analyte) and amobarbital (a reference compound serving as the "internal standard" for determining cross-contributions of intensities for ions designated for the analyte and the IS) in 1 mg/mL methanol solution (99% purity) and 2Hs-butalbital (an IS) in 0.1 mg/mL methanol solution (99% purity) were purchased from Radian (Austin, TX).
Reagents used for methylation of the anaIyte (and the ISs), tetramethylammonium hydroxide (TMAH, 25% in methanol), iodomethane, and dimethylsulfoxide (DMSO), were purchased from Aldrich (Milwaukee, WI). Bond Elut Certify TM solid-phase extraction columns were obtained from Analytichem International, Varian (Harbor City, CA). Drug-free urine used for the preparation of standard drug solutions was collected from one member of the investigation team.
A series of standard solutions (in pH 5.8 urine) containing the following concentrations of butalbital were prepared from a single source of stock containing 0.01 mg/mL butalbital: 25, 50, 100, 200, 500, 800, 1000, 1250, 1600, 2000, 2500, 3200, 4000, and 5000 ng/mL. A single stock was used so that source difference can be ruled out as the source of any deviation from linearity that may be observed.
Solid-phase extraction and derivatization
Each sample includes 2 mL standard solution (of various concentrations) and 40 pL 10-pg/mL IS (final IS concentration: 200 ng/mL). Procedures provided by the manufacturer of Bond Elute Certify were followed (15) . Briefly, 0.8 mL 0.1M phosphate buffer (pH 6.0) was added to each sample (range of pH in these samples: 5.8-6.3). Conditioned column was applied the samples, rinsed, then eluted with 4 mL hexane/ethyl acetate into a disposable 5-mL glass centrifuge tube. The extract was dried, methylated, and then cleaned following the exact procedures described in our earlier report (7) . Final product was dried and reconstituted with 20 pL (or other specified volumes) ethyl acetate prior to GC-MS measurement.
GC-MS analysis
With some minor changes in GC conditions, the same instrumentation and procedures (HP 5890 GC interfaced to an HP 5970 mass selective detector) used in our earlier study (7) were adapted. Initial temperature (80~ was programmed to 170~ at 18~ then to 260~ at 30~ and held for 3 min. 
Cross-contribution evaluation
Full-scan mass spectrometric data were used for initial selection of ions designated for the analyte and ISs. Specifically, ions with high intensities and mass and with apparently no or insignificant cross-contribution were initially selected. Crosscontribution to the intensities of these ions (by their counter part: analyte or IS) are more precisely determined by two procedures ("improved direct measurement" and "internal standard method") as described here subsequently. (See a separate report exploring various methods for cross-contribution evaluation [16] .) Improved direct measurement (IDM) . SIM data were collected using 5 pg (500-pL of 10 pg/mL standard solution) of butalbital, 2Hs-butalbital, and 13C4-butalbital, respectively. This approach assumes that equimolar amounts of the isotopic analogues produce the same base-ion intensities. Thus, the intensities of ions observed from two separate experiments for the isotopic-analogue pairs (butalbital/2Hs-butalbital and butalbital/13C4-butalbital) were first normalized with the assumption that the intensities of their respective base-ions are the same. Normalized data were considered true ion intensities (that were generated by the same amount of these two compounds in the isotopic-analogue pair) and used to calculate cross-contribution data.
This approach compensates for variations in the quantities of the analyte and the labeled-analogue (introduced into the GC-MS system for ion intensity measurements) that might have derived from: (1) errors associated with the pipetting process and the exact concentrations of the standards; (2) variations in achieving the same degree of completeness in the derivatization step; and (3) non-reproducibility in providing the exact GC-MS conditions (in separate experiments) for ion intensity measurement.
Internalstandard method (ISM). The same procedures and quantities of butalbital, 2H~-butalbital, and 13C4-butalbital (that were used for the IDM method) were used. In addition, a set amount (100 pL of 1 pg/mL standard solution) of a third compound (amobarbital) was used as the internal standard and incorporated into each experiment for these three compounds. Variations in GC-MS conditions and completeness of the derivatization step were compensated for by normalizing the observed intensities of the ions of interest (designated for butalbital, 2H5-butalbital, and 13C4-butalbital) to the intensity of a selected ion, (m/z 169) derived from the set amount of the internal standard (amobarbital), that was observed in respective experiments. Amobarbital was adapted as the internal standard for this purpose because of its similarities in structural and spectral characteristics and chromatographic properties.
Results and Discussion
Cross-contribution evaluation
Full-scan mass spectra and the structural characteristics of butalbital, 2H5-butalbital, and 13C4-butalbital are shown in Figure 1 . Full-scan relative intensity and SIM intensity data of selected ions and percent cross-contributions of these ions derived from the IDM and ISM approaches are summarized in Table I . Figure 2 depicts major fragmentation pathways responsible for ions with prominent intensities (17) . These pathways illustrate the point that placing labeling isotopes (2H or 13C) at appropriate positions in the molecular framework is essential to the synthesis of effective ISs; they do not, however, identify the sources of cross-contributing ions. (Cross-contributing ions have low intensities and pathways leading to the generation of these ions are, in general, not well understood.)
Both IDM and ISM approaches result in the same order, among ions designated for each compound, in the extents of their being contaminated by the presence of the counter-component in the isotope-analogue pair. Because the intensities of all ions designated for each compound were collected from the same analytical run, relative magnitudes of these crosscontribution data truly reflect the relative extents of these ions being contaminated. Thus, having adapted a specific labeled analogue as the IS in a quantitative analysis protocol, both approaches can be effectively used to select the best ion pair. ISM approach are believed to truly reflect their relative magnitudes. Compatibility of these data is the result of normalizing all intensity data to a single internal standard (intensities of m/z 169 derived from a set amount of amobarbital) incorporated into each analytical run. These data also represent the absolute magnitudes of cross-contributions examined, subject to experimental errors. Whether the relative and absolute magnitudes of the intercompound and intersystem cross-contribution data, derived from the IDM approach, are representative depends on the validity of the assumption adapted in this approach: the intensities of the base ions derived from these compounds are the same. Because ion fragmentation mechanism is subjected to isotopic effects, this assumption is theoretically invalid. Deviations from this assumption varies with the type and the position of the isotopes that were placed in the molecular frameworks of the labeled analogues. It is comfortable to note that intercompound and intersystem cross-contribution data (Table I) derived from the IDM approach are compatible to that derived from the ISM approach, indicating isotopic effects do not play a significant role in altering the intensities of ions designated for these labeled analogues.
Cross-contribution data shown in Table I provide the following observations: (1) both labeled analogues (13C4-butalbital and 2Hs-butalbital) cause more significant cross-contribution to ions designated for butalbital than butalbital to the labeled analogues; (2) compared with 2Hs-butalbital, 13C 4-butalbital appears to cause less cross-contribution to ions designated for butalbital; and (3) 
Effectiveness of 2Hs-butalbital and 13C4-butalbital as internal standards
Standard solutions containing butalbital in the range of 25-5000 ng/mL were used for calibration studies to evaluate the effectiveness of 2Hs-butalbital and ]3C4-butalbital as IS. One-point calibration model (calibrator 200 ng/mL) was used to derive the observed analyte concentrations. Results are shown in Tables II and III. Percent deviation data shown in Table II (13C4-butalbital Systematic errors become obvious when examining the percent deviation data derived from ion pairs m/z 138/141 (Table  II: 13C4-butalbital as IS) and m/z 138/143 (Table III: 2H5-butalbital as IS). Systematic derivations are obvious because the analyte makes significant cross-contributions to the ions designated for the ISs and because the relatively high analyte concentration changes in these two series of standard solutions. Again, this is consistent with the cross-contribution data shown in Table I .
One additional observation: the absolute deviation values observed for ion pair m/z 138/141 (Table II) is lower than that observed for m/z 138/143 (Table III) . This is a good indication that the absolute cross-contribution for the analyte to the IS in the butalbital/13C4-butalbita] system is less than that in the butalbital/2Hs-butalbital system. This information can be used to validate the relative cross-contribution data between these two system as shown in Table I .
Intramolecular ion pair intensity ratio as a basis for evaluating cross-contribution and its effect on calibration linearity
Deviations of the observed analyte concentrations from the theoretical values shown in Tables II and III are consistent with the cross-contribution data shown in Table I . These relationship can be further established by looking at intramolecular ion pair intensity ratios. Variation of intramolecular ion intensity ratios in a series of standard solutions with different analyte concentrations also reveals relative degrees of these ions in receiving cross-contribution caused by the presence of the isotopic analogue.
Relevant intramolecular ion pair intensity ratios to be examined are shown in Tables IV (for the butalbital/13C4 -butalbital system) and V (for the butalbital/2Hs-butalbital system). These numerical data are informative; however, because changes can be very small and random errors are inadvertently imbedded in all determinations, it is difficult to evaluate ratio changes relying on visual comparisons of individual numerical data. Instead, statistical trends (as plotted in Figure 3 ) of these data can serve as a more effective basis for evaluation.
Intramolecular ion intensity plots shown in Figure 3 Table I. These plots, however, are generally not effective in showing the relative extents of cross-contribution made by the labeled analogues to the analyte. This is because of the relatively low concentration of the labeled analogues, compared with that of the analyte, in the entire series of standard solutions. The effects of their crosscontribution are hardly noted, especially at the higher concentration end of the calibration solutions.
However, clearer trends can be shown by plotting the intramolecular ion intensity ratios in the regions in which the relative change in the analyte/labeled-analogue concentrations are significant. Thus, Figure 4 are plots of the same data used for Figure 3D Table I . (Changes in the sign of slope of these plots at the higher concentration end are indications that the effect of the cross-contribution made by 2H 5-butalbital is now not a significant factor.)
Concentration dependency of analyte/labeled-analogue ion pair intensity ratio
One main objective of this study is to investigate whether the concentration dependency of analyte/labeled-analogue ion pair intensity ratio observed in the secobarbita~Hs-secobarbital system (but not in the secobarbitalP3C4-secobarbital system) also exists in parallel butalbital systems (9) . Data shown in Table VI confirm the existence of this same characteristic. Specifically, for the butalbital/~Hs-butalbital system, the analyte/labeled-analogue ion pair intensity ratios increase as the volume of the solvent used to reconstitute the extractionderivatization product is increased (data shown in the lefthand section of Table VI) . Like the parallel secobarbital system, this phenomenon does not exist in the butalbital/13C4-butalbital system (data shown in the right-hand section of Table VI ). This phenomenon is further studied by a series of extended dilutions using one analyte concentration level (2500 ng/mL). Data shown in Table VII again confirm the difference between the butalbital/2Hs-butalbital (data shown in the lefthand section of Table VII, Figure 5 ) and the butalbital/13C4 -butalbital (data shown in the right-hand section of Table  VII) systems.
The data shown in Tables VI and VII indicate the following characteristics: (1) intensity ratios for the designated ion-pairs in the butalbital/13C4-analogue system remain constant, while the parallel ratios in the butalbita~Hs-analogue system increase as the volume of solvent used for reconstitution increases and (2) the magnitude of the observed increase (for the butalbita~Hs-analogue system) is higher when the analyte concentration is higher. The increase become insignificant (or not noticeable) when the analyte concentration is approximately 200 ng/mL (Table VI) . This concentration dependency phenomenon observed for the analyte/2Hs-analogue systems has a serious implication, that is, the concentration (which is unknown) in a test sample can be accurately determined only if the test sample is reconstituted with the same solvent volume as every calibration standards. Reconstitution with smaller or larger solvent volume for test samples or any calibration standard will result in non-representative ion-pair intensity ratios.
Mechanisms for concentration-dependent ion pair intensity ratio
The exact mechanism causing the observed concentrationsensitive nature of the ion-pair intensity ratio, that are observed in the butalbital/2Hs-analogue and the previously reported secobarbita~Hs-secobarbital systems, is still under investigation (9) . This phenomenon may be associated with the Journal of Analytical Toxicology, Vol. 25, November/December 2001 placement of 2H-atoms at active sites of the molecular structure resulting in 2H/1H-exchange at the ion source of the mass spectrometer.
Alternatively, the retention time difference between the analytes and the 2Hs-analogues can be the underlying factor. Retention times of 13C4-butalbita] and 13C4-secobarbital are the same as their 12C-analogues (see Figure 6 for the single-ion chromatogram for the butalbital/I3C4-butalbital system). Single-ion chromatograms shown in Figure 7 indicate the elutions of butalbital and 2Hs-butalbital take place in three phases: 2Hs-butalbital alone, coelution of butalbital and 2Hs-butalbital, and butalbital alone. The overlapping nature of these two compounds may have resulted in non-proportional overall changes in ionization efficiencies when the sample is eluted into the ion sources with different molecular populations. It has been reported that coelution of fluconazole caused reduced responses of benzoylecgonine and the coeluting benzoylecgonine-d3 IS (18) . This "coeluting interference" was attributed to "saturation of the ionization chamber", but the authors did not report non-proportional reduction of the benzoylecgonine/benzoylecgonine-d3 ion pair. If retention time difference is indeed the underlying factor, the wisdom in using excessive number of 2H-atoms for manufacturing ISs may need to be reconsidered. On the other hand, if 2H/1H-exchange is the underlying factor, the positioning of 2H-atoms placement should be more selective.
Conclusions
"Improved direct measurement" and "internal standard" protocols can be used to determine relative cross-contribution data (made by the analyte and its isotopic analogue) to the intensity of ions designated for the measurements of their abundance. Systematic increase (or decrease) of intramolecular ion intensity ratio changes in a series of standard solutions further provide the relative degrees of cross-contribution these ions received from the isotopic analogue examined. For those ion pairs with significant cross-contributions, magnitudes of the observed systematic deviations (from their respective theoretical concentration values) in a series of standard solutions 18.
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.=. are also indications of relative degrees of intercompound and inter-system (analyte/isotopic analogue) cross-contributions. For the butalbital/13C4-butalbital system, the following ion pairs have negligible cross-contributions and can be effectively used for quantitation purposes: m/z 196/200, 195/199, and 181/185. For the butalbital/2Hs-butalbital system, ion pair m/z 196/201 is equally effective. However, because of high crosscontribution of 2Hs-butalbital to ions designated for butalbital, ion pairs m/z 195/200 and 181/184 are not effective and produce significantly higher observed values when the analyte concentration is lower than that of the IS. Because of high cross-contributions made by the analyte (to the ISs), ion pairs m/z 138/141 (for the butalbital/13C4-butalbital system) and 138/143 (for the butalbital/2Hs-butalbital system) produce systematically lower results as the analyte concentration increases. Relative magnitude of the systematic errors observed in these two system suggests the extent of cross-contribution in the former system is not as serious as that of the latter one.
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It is also concluded that the butalbital/2Hs-butalbital system exhibits the same concentration dependency phenomenon observed in the secobarbital/2Hs-secobarbital system, that is, intensity ratios of ion pairs designated for these two isotopic analogues (resulting from routine GC-MS protocols) increase as they are reconstituted with increasingly larger solvent volumes prior to GC-MS determination. This phenomenon is particularly significant when the analyte concentration is high. Retention time difference between these two compounds may have resulted in overall non-proportional changes in ionization efficiencies during their entire residency at the ion source of the mass spectrometer. Or, alternatively, the observed phenomenon is caused by 2H/1H-exchange at the ion source of the mass spectrometer.
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